Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Oncology Drug Market, Global Research Reports 2020-2021

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Oncology Drug Industry
  • 1.7 COVID-19 Impact: Oncology Drug Market Trends

    • 2 Global Oncology Drug Quarterly Market Size Analysis

    • 2.1 Oncology Drug Business Impact Assessment - COVID-19
      • 2.1.1 Global Oncology Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Oncology Drug Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Oncology Drug Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Oncology Drug Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Oncology Drug Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Oncology Drug Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Oncology Drug Market
    • 3.5 Key Manufacturers Oncology Drug Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Oncology Drug Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Chemotherapy
      • 1.4.2 Targeted Therapy
      • 1.4.3 Immunotherapy
      • 1.4.4 Hormonal Therapy
      • 1.4.5 Others
    • 4.2 By Type, Global Oncology Drug Market Size, 2019-2021
      • 4.2.1 By Type, Global Oncology Drug Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Oncology Drug Price, 2020-2021

    5 Impact of Covid-19 on Oncology Drug Segments, By Application

    • 5.1 Overview
      • 5.5.1 Blood Cancer
      • 5.5.2 Breast Cancer
      • 5.5.3 gastrointestinal Tract Cancer
      • 5.5.4 Prostate Cancer
      • 5.5.5 Lung Cancer
      • 5.5.6 Skin Cancer
    • 5.2 By Application, Global Oncology Drug Market Size, 2019-2021
      • 5.2.1 By Application, Global Oncology Drug Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Oncology Drug Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Roche Ltd
      • 7.1.1 Roche Ltd Business Overview
      • 7.1.2 Roche Ltd Oncology Drug Quarterly Production and Revenue, 2020
      • 7.1.3 Roche Ltd Oncology Drug Product Introduction
      • 7.1.4 Roche Ltd Response to COVID-19 and Related Developments
    • 7.2 Novartis AG
      • 7.2.1 Novartis AG Business Overview
      • 7.2.2 Novartis AG Oncology Drug Quarterly Production and Revenue, 2020
      • 7.2.3 Novartis AG Oncology Drug Product Introduction
      • 7.2.4 Novartis AG Response to COVID-19 and Related Developments
    • 7.3 Bristol-Myers Squibb
      • 7.3.1 Bristol-Myers Squibb Business Overview
      • 7.3.2 Bristol-Myers Squibb Oncology Drug Quarterly Production and Revenue, 2020
      • 7.3.3 Bristol-Myers Squibb Oncology Drug Product Introduction
      • 7.3.4 Bristol-Myers Squibb Response to COVID-19 and Related Developments
    • 7.4 Celgene Corporation
      • 7.4.1 Celgene Corporation Business Overview
      • 7.4.2 Celgene Corporation Oncology Drug Quarterly Production and Revenue, 2020
      • 7.4.3 Celgene Corporation Oncology Drug Product Introduction
      • 7.4.4 Celgene Corporation Response to COVID-19 and Related Developments
    • 7.5 Johnson & Johnson
      • 7.5.1 Johnson & Johnson Business Overview
      • 7.5.2 Johnson & Johnson Oncology Drug Quarterly Production and Revenue, 2020
      • 7.5.3 Johnson & Johnson Oncology Drug Product Introduction
      • 7.5.4 Johnson & Johnson Response to COVID-19 and Related Developments
    • 7.6 Pfizer Inc.
      • 7.6.1 Pfizer Inc. Business Overview
      • 7.6.2 Pfizer Inc. Oncology Drug Quarterly Production and Revenue, 2020
      • 7.6.3 Pfizer Inc. Oncology Drug Product Introduction
      • 7.6.4 Pfizer Inc. Response to COVID-19 and Related Developments
    • 7.7 Astra Zenca Plc
      • 7.7.1 Astra Zenca Plc Business Overview
      • 7.7.2 Astra Zenca Plc Oncology Drug Quarterly Production and Revenue, 2020
      • 7.7.3 Astra Zenca Plc Oncology Drug Product Introduction
      • 7.7.4 Astra Zenca Plc Response to COVID-19 and Related Developments
    • 7.8 Eli Lilly And Company.
      • 7.8.1 Eli Lilly And Company. Business Overview
      • 7.8.2 Eli Lilly And Company. Oncology Drug Quarterly Production and Revenue, 2020
      • 7.8.3 Eli Lilly And Company. Oncology Drug Product Introduction
      • 7.8.4 Eli Lilly And Company. Response to COVID-19 and Related Developments
    • 7.9 Glaxosmithkline Plc
      • 7.9.1 Glaxosmithkline Plc Business Overview
      • 7.9.2 Glaxosmithkline Plc Oncology Drug Quarterly Production and Revenue, 2020
      • 7.9.3 Glaxosmithkline Plc Oncology Drug Product Introduction
      • 7.9.4 Glaxosmithkline Plc Response to COVID-19 and Related Developments
    • 7.10 Merck & Co.
      • 7.10.1 Merck & Co. Business Overview
      • 7.10.2 Merck & Co. Oncology Drug Quarterly Production and Revenue, 2020
      • 7.10.3 Merck & Co. Oncology Drug Product Introduction
      • 7.10.4 Merck & Co. Response to COVID-19 and Related Developments
    • 7.11 Sanofi
      • 7.11.1 Sanofi Business Overview
      • 7.11.2 Sanofi Oncology Drug Quarterly Production and Revenue, 2020
      • 7.11.3 Sanofi Oncology Drug Product Introduction
      • 7.11.4 Sanofi Response to COVID-19 and Related Developments
    • 7.12 Amgen Inc.
      • 7.12.1 Amgen Inc. Business Overview
      • 7.12.2 Amgen Inc. Oncology Drug Quarterly Production and Revenue, 2020
      • 7.12.3 Amgen Inc. Oncology Drug Product Introduction
      • 7.12.4 Amgen Inc. Response to COVID-19 and Related Developments
    • 7.13 Abbvie
      • 7.13.1 Abbvie Business Overview
      • 7.13.2 Abbvie Oncology Drug Quarterly Production and Revenue, 2020
      • 7.13.3 Abbvie Oncology Drug Product Introduction
      • 7.13.4 Abbvie Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Oncology Drug Supply Chain Analysis
      • 8.1.1 Oncology Drug Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Oncology Drug Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Oncology Drug Distribution Channels
      • 8.2.2 Covid-19 Impact on Oncology Drug Distribution Channels
      • 8.2.3 Oncology Drug Distributors
    • 8.3 Oncology Drug Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Oncology Drug, including the following market information:
      Global Oncology Drug Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Oncology Drug Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Oncology Drug Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Oncology Drug Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)

      Key market players
      Major competitors identified in this market include Roche Ltd, Novartis AG, Bristol-Myers Squibb, Celgene Corporation, Johnson & Johnson, Pfizer Inc., Astra Zenca Plc, Eli Lilly And Company., Glaxosmithkline Plc, Merck & Co., Sanofi, Amgen Inc., Abbvie, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Chemotherapy
      Targeted Therapy
      Immunotherapy
      Hormonal Therapy
      Others

      Based on the Application:
      Blood Cancer
      Breast Cancer
      gastrointestinal Tract Cancer
      Prostate Cancer
      Lung Cancer
      Skin Cancer

      Buy now